---
title: "CHISON MEDICAL: Shareholders plan to collectively reduce their holdings in the company by no more than 1.72%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237702477.md"
description: "On the evening of April 27th, CHISON MEDICAL announced that its shareholders Wuxi Xiangding Investment Enterprise, Shanghai Yude Technology Co., Ltd., and Wuxi Xiangpeng Investment Enterprise plan to reduce their holdings in the company by a total of no more than 1.932 million shares, which is no more than 1.72% of the company's total share capital"
datetime: "2025-04-27T10:23:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237702477.md)
  - [en](https://longbridge.com/en/news/237702477.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237702477.md)
generator: "portal-rs"
---

# CHISON MEDICAL: Shareholders plan to collectively reduce their holdings in the company by no more than 1.72%

On the evening of April 27th, CHISON MEDICAL announced that its shareholders Wuxi Xiangding Investment Enterprise, Shanghai Yude Technology Co., Ltd., and Wuxi Xiangpeng Investment Enterprise plan to reduce their holdings in the company by a total of no more than 1.932 million shares, which is no more than 1.72% of the company's total share capital

### Related Stocks

- [688358.CN](https://longbridge.com/en/quote/688358.CN.md)

## Related News & Research

- [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md)
- [YMTC's STAR Mkt IPO Application Accepted, w/ Plans to Raise RMB33B](https://longbridge.com/en/news/296724109.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [Australia says Roblox hasn’t fixed its child predator problem](https://longbridge.com/en/news/296523838.md)
- [16:48 ETGI MAP Test Launches Cyclospora Guidance Service for Customers With a Detected Test Result](https://longbridge.com/en/news/296535077.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**